Antitrust risk in a merger is best managed as a continuous process, not a closing checklist. Legal practitioners at Vinson & Elkins, summarizing a discussion between their antitrust partners, put the core principle plainly: the earlier a company assesses antitrust risk, the better positioned it will be to address regulatory concerns. The practical answer for executives is a three-stage framework — early and continuous assessment, in-depth analysis aligned with how regulators actually think, and strategic engagement with the agencies — supported by a clear decision about when internal teams suffice and when outside advisors are essential.

Introduction: Proactive Antitrust Risk Management in M&A

Two forces make proactive antitrust management a board-level issue. First, the legal standard is deliberately forgiving to enforcers: the U.S. Department of Justice's Merger Guidelines explain that under Section 7 of the Clayton Act, a plaintiff need only prove that a merger's effect "may be substantially to lessen competition" or tend to create a monopoly — not that it certainly will. The agencies examine the totality of the evidence to assess risk, rather than predicting outcomes with certainty. Second, the enforcement climate has grown more demanding. Gibson Dunn's antitrust team observed that mergers in industries already under investigation for anticompetitive practices may face "more intense and searching scrutiny," and that dealmakers should prepare for a broader and more extended period of agency review.

One structural checkpoint anchors the formal process: transactions that meet the Hart-Scott-Rodino Act's size-of-transaction and size-of-person thresholds must be notified to the federal agencies before closing. Those dollar thresholds are adjusted periodically, so executives should confirm the current figures with official FTC and DOJ sources rather than rely on any static number. This article addresses U.S. antitrust risk only and is a general framework, not legal advice.

Stage 1: Early & Continuous Assessment

The first stage begins before the deal is fully formed. Vinson & Elkins' Kara Kuritz captures the inherent tension: "You want to do it as early as possible…but understanding that the earlier you are in the deal process, the less information you likely have. It's an ongoing analysis that you continue to update and refine as more information becomes available." That means the initial screen is deliberately rough — identifying the overlapping markets, the combined market position, and any industry context that could invite heightened scrutiny — and then refreshing it as diligence data arrives.

Early assessment also has a documentary dimension. The Conference Board's guidance to chief legal officers warns that "economic models will probably not save you if you have bad emails," and urges companies to educate the CEO, the C-suite, and everyone involved in strategic planning to avoid creating documents that an enforcement agency could misinterpret. Executives should also assess the deal's potential impact on labor markets, not only on consumer welfare, and expect any noncompete terms to draw close scrutiny.

Stage 2: In-Depth Analysis Based on Regulatory Principles

Once a target is serious, internal analysis should mirror the agencies' own method. The Merger Guidelines state that the agencies begin by asking two questions: how do firms in this industry compete, and does the merger threaten to substantially lessen competition or tend to create a monopoly? The Guidelines then set forth several analytical frameworks to help the agencies determine whether a merger presents sufficient risk to warrant enforcement. A company that answers those questions internally, using the same frameworks, can anticipate where regulators will focus.

Deal terms deserve the same rigor. The Conference Board advises CLOs to focus on the allocation of risk for post-closing government antitrust investigations — who bears the cost if the agency comes back after the deal closes. Companies should also remember that federal compliance does not necessarily resolve state-law exposure; law firm SJKP notes that state laws may impose additional requirements, so businesses operating across jurisdictions should assess which laws apply rather than assume federal compliance is sufficient.

Stage 3: Strategic Engagement with Regulators

The final stage converts analysis into advocacy. Vinson & Elkins reports that proactive engagement can help the agencies put the deal in context and narrow down concerns more quickly, and that companies adopting a thoughtful, strategic and well-documented approach will be better positioned for successful deal execution. Engagement is not a substitute for a clean competitive story — it is a way to frame the evidence the agencies will examine under their totality-of-the-evidence approach.

Practically, this stage means deciding early whether the deal narrative supports a straightforward review or will require remedies, and building the timeline accordingly. Given that reviewers should prepare for extended agency review periods, engagement planning belongs in the deal calendar from the outset, not after a second request arrives.

M&A Antitrust Risk Assessment Framework

The framework below maps each stage to the key questions executives should ask and the internal actions that follow, alongside the regulatory perspective driving them. Use it as a roadmap: at any point in a live deal, locate your stage and confirm the questions in that row have been answered and documented.

Three-stage framework for assessing and managing antitrust risk in an M&A transaction
Assessment StageKey QuestionsInternal ActionsRegulatory Perspective
Early & Continuous Assessment Where do we overlap with the target? Is our industry under antitrust investigation? What documents are we creating? Run an initial market-overlap screen; refresh as diligence data arrives; train the C-suite and deal teams to avoid creating misinterpretable documents. Agencies assess risk from the totality of the evidence; a low liability threshold ("may substantially lessen competition") means early red flags matter.
In-Depth Analysis How do firms in this industry compete? Does the merger threaten to substantially lessen competition or create a monopoly? What is the labor-market impact? Apply the Merger Guidelines' analytical frameworks internally; assess labor-market effects and noncompete terms; allocate post-closing investigation risk in deal terms; check state-law exposure. The Merger Guidelines direct agencies to begin with how competition works and whether the merger threatens it, using defined frameworks to decide on enforcement.
Strategic Engagement What is our deal narrative? Where will the agencies focus? Do we need remedies, and on what timeline? Engage agencies proactively to put the deal in context; document the approach; plan for extended review periods in the deal calendar. Proactive engagement helps agencies narrow concerns more quickly, per Vinson & Elkins' practitioners.

Internal vs. External Expertise: When to Seek Advisors

The M&A Leadership Council lays out the decision factors directly. An internal assessment offers cost savings by avoiding high consultant fees, deeper understanding of the target, customization to your specific objectives, and confidentiality. Its challenges are equally concrete: the team must genuinely possess financial, legal, operational and strategic expertise; internal familiarity can breed bias and cause critical risks to be overlooked; and a stretched timeline can compromise thoroughness.

External advisors become the better choice, on that guidance, when the transaction involves complex financial structures, cross-border elements or significant regulatory considerations; when internal M&A experience is thin; when an independent perspective is crucial; or when the timeline is tight. Many organizations use a hybrid: the internal team conducts preliminary assessments, gathers data and flags initial concerns, while outside experts provide specialized legal and financial expertise, validate internal findings, and handle complex analysis. Note that the DOJ itself treats risk assessment as one of nine essential elements of an effective compliance program, which strengthens the case for building this capability internally even when outside counsel leads the deal-specific work.

Proactive Management for Deal Approval

C-suite executives should implement a structured, three-stage antitrust risk assessment framework from the earliest stages of M&A to proactively identify and mitigate regulatory challenges. The framework's value is that it aligns the company's internal diligence with the questions the agencies are legally required to ask, and it forces the resourcing decision — internal, external or hybrid — to be made deliberately rather than by default. The measurable indicator of success is deal approval without significant regulatory delays or concessions, indicated by timely clearance under the Hart-Scott-Rodino process and positive agency feedback. Executives should treat any second request, extended review, or negotiated divestiture as a signal to revisit the framework's earlier stages on the next transaction.

Sources